💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Xinhua

Published 08/07/2018, 05:25 AM
Updated 08/07/2018, 05:30 AM
© Reuters. FILE PHOTO: Logo of vaccine maker Changsheng Bio-technology Co Ltd is seen at its building in Changchun

SHANGHAI (Reuters) - Changsheng Bio-technology Co Ltd, a vaccine maker at the center of a safety scandal in China, began falsifying production records for its rabies vaccine in April 2014, state news agency Xinhua reported on Tuesday.

Changsheng had mixed some batches with expired solution and did not correctly record dates or batch numbers, Xinhua said, citing the findings of an investigation team established by China's State Council.

© Reuters. FILE PHOTO: Logo of vaccine maker Changsheng Bio-technology Co Ltd is seen at its building in Changchun

China launched sweeping spot checks at vaccine makers around the country last month in a bid to rein in public outrage after Changsheng was found to have falsified data for the rabies vaccine and manufactured an ineffective vaccine for Chinese babies.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.